Clinical Trial Update: Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva [NA]

View source ↗

Summary

Clinical trial evaluating topical imiquimod for recurrent Paget's disease of the vulva has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paget Disease of the Vulva
• Vulvar Cancer

Drugs mentioned

• Imiquimod (imiquimod)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Vulvar Cancer | NA | Status: COMPLETED | Results posted: 2018-05-08